These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 31452270)
21. Long non-coding RNAs orchestrate various molecular and cellular processes by modulating epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Sharma A; Kansara S; Mahajan M; Yadav B; Garg M; Pandey AK Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166240. PubMed ID: 34363933 [TBL] [Abstract][Full Text] [Related]
22. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539 [TBL] [Abstract][Full Text] [Related]
23. Hypomethylated SPANXA1/A2 promotes the metastasis of head and neck squamous cell carcinoma. Li J; Bo H; Zhu F; Li Q; Chen T; Lei S; Fan L Med Oncol; 2020 Nov; 37(12):112. PubMed ID: 33175201 [TBL] [Abstract][Full Text] [Related]
24. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway. Liu W; Yao Y; Shi L; Tang G; Wu L J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929 [TBL] [Abstract][Full Text] [Related]
25. Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma. Zou AE; Ku J; Honda TK; Yu V; Kuo SZ; Zheng H; Xuan Y; Saad MA; Hinton A; Brumund KT; Lin JH; Wang-Rodriguez J; Ongkeko WM RNA; 2015 Jun; 21(6):1122-34. PubMed ID: 25904139 [TBL] [Abstract][Full Text] [Related]
26. Increased FGL1 Expression Predicts Poor Prognosis and Promotes EMT in Head and Neck Squamous Cell Carcinoma. Pan Z; Hu W; Huang J; Zheng Z; Lin E; Wang P; Mao L Biochem Genet; 2024 Jun; 62(3):2066-2081. PubMed ID: 37843652 [TBL] [Abstract][Full Text] [Related]
27. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
28. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma. Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185 [TBL] [Abstract][Full Text] [Related]
29. P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway. Wang Q; Meng D; Shen S; Cao Y; Zhang P; Liu Y; Du L; Li H; Shao C; Dong Q Pathol Res Pract; 2024 Aug; 260():155481. PubMed ID: 39053135 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma. Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206. Xue K; Li J; Nan S; Zhao X; Xu C Life Sci; 2019 Aug; 231():116459. PubMed ID: 31075234 [TBL] [Abstract][Full Text] [Related]
32. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma. Wang J; Bian Q; Liu J; Moming A Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450 [TBL] [Abstract][Full Text] [Related]
33. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway. Wu YL; Liu W; Zhao T; Jin J Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998 [TBL] [Abstract][Full Text] [Related]
34. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
35. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma. Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710 [TBL] [Abstract][Full Text] [Related]
37. Periostin Plays a Key Role in Radioresistance of Head and Neck Cancer Cells Park JJ; Hah YS; Ryu S; Cheon SY; Cho HY; Kim JP; Won SJ; Lee JS; Hwa JS; Seo JH; Chang HW; Kim SY Anticancer Res; 2020 May; 40(5):2627-2635. PubMed ID: 32366407 [TBL] [Abstract][Full Text] [Related]
38. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway. Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809 [TBL] [Abstract][Full Text] [Related]
39. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition. Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049 [TBL] [Abstract][Full Text] [Related]
40. LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression. Ying Y; Liu D; Zhao Y; Zhong Y; Xu X; Luo J; Zhang Z Comput Math Methods Med; 2022; 2022():2857022. PubMed ID: 35756415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]